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Abstract 
 
Scientists have long wondered why some individuals are more sensitive to pain 
than others. While individual differences in pain have traditionally been discounted due 
to neuroticism, research has shown that individuals who are more sensitive to pain 
demonstrate real biological differences in pain perception (Coghill, McHaffie & Yen, 
2003). However, individual differences in pain sensitivity remain under-explored in 
research and clinical settings that can provide further insights into clinical disorders such 
as addiction. The current research review is interested in examining the link between pain 
sensitivity and alcohol dependence. Investigating the relationship between pain 
sensitivity and alcohol addiction prompts many important peripheral questions such as 
whether increased pain sensitivity can serve as a useful biomarker for alcohol addiction, 
and how addiction to alcohol can cause changes in sensitivity to pain. Addiction potential 
or risk for addiction is a research area that is extremely important given that the high rate 
of addiction in this country is alarmingly high. The literature is sparse on the relationship 
between hyperalgesia or pain sensitization and risk for alcohol addiction. This literature 
review synthesizes current relevant research on pain and addiction, as well as addressing 
possible links between them.  
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Introduction 
 
Is there a link between pain sensitivity and alcohol addiction? People have often 
wondered why some individuals are more sensitive to pain and often complain about it, 
while others are impervious to everyday simple pains. As high rates of addiction continue 
to loom, the current scientific inquiry centers on relapse prevention. This innovative 
report explores the current literature on pain sensitivity, alcohol addiction, and the links 
they share, and is the first examination of its kind. While there have been a few studies on 
pain in patients with alcoholism, there is a deficit in the current literature as to whether 
greater initial individual sensitivity to pain may be a precursor for addiction. While the 
answer to this question is beyond the scope of this report, it is hoped that interest in this 
area will be stimulated. The present master’s report is organized into three sections. In the 
first section, individual differences in pain perception are reviewed. The second section 
provides a short overview of alcoholism and vulnerabilities for developing alcohol 
dependence. The third and final section is focused on the links between them including 
shared neurobiological processes.  
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Chapter One:  
Pain Sensitivity  
Scientists have long wondered why some individuals are more sensitive to pain 
than others. Chapman and Jones (1944) conducted early research in the field of individual 
differences in pain perception. They interpreted their findings by categorizing the 
perception of pain as a sensory phenomenon, and the reaction to pain as a psychological 
phenomenon that may have vast clinical importance. Pain perception was defined as the 
subjective end-point by which participants first noticed the stimulus to be painful, and 
defined pain reaction as evidence of subjects’ objective withdrawal from the pain 
stimulus. They found that both pain perception and pain reaction decreased with 
increasing age, and that while there was a small amount of variation within the 
individual, there was substantial variation between individuals to both pain perception 
and pain reaction (Chapman & Jones, 1943).  
An individual’s perception of pain is affected by a combination of the individual’s 
emotions, damage to the body, genetics, and their expectations of pain (Hampton, 2006). 
In a review on pain, Coghill (2010) argued that while individuals’ subjective experiences 
to sensory phenomena remain unique, differences between individuals’ sensory 
experiences are derived from past experiences, the present environment, and future 
expectations. Additional research has shown that individuals who are more sensitive to 
pain demonstrate true differences in nociceptive processing (Coghill, McHaffie & Yen, 
2003). Pain sensitivity is affected by three sets of factors that interact in complicated and 
multifaceted ways. Biological factors such as brain differences, sociocultural factors such 
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as gender roles, ethnicity, etc., genetics, and psychological factors such as mental illness, 
all mediate an individual’s sensitivity to pain (Wiesenfeld-Hallin,, 2005).  
 
Brain Differences in Pain Sensitivity 
Although previously assumed a to be a passive and fixed relay system, pain 
perception is now understood to function as an active and complicated integrated system 
that is contingent upon the interactions of inhibitory and excitatory neurons (McGrath, 
1994). Due to the high variability between individuals in subjective pain intensity, 
medical professionals have often wondered whether these differences are real or whether 
pain sensitive individuals are histrionic or drug seekers (Coghill, 2010). However, the 
between subject differences in brain regions that respond to pain have been shown to be 
consistent with inter-individual variability in pain intensity ratings, which provide 
support that individual differences in pain are genuine (Coghill, 2010). In an earlier 
study, Coghill and colleagues found within-individual differences in brain activation in 
the primary somatosensory cortex and anterior cingulate, in that activation increased in 
magnitude relative to pain stimulus intensity or its perceived intensity, which provided 
further support for the validity of individual variability in pain (Coghill, Sang, Maisog & 
Iadarola, 1999).   
Coghill, McHaffie, and Yen (2003) conducted a functional neuroimaging study 
examining the neural correlates of thermal pain in normal control participants grouped as 
either low or high pain sensitive after subjectively rating their pain intensity. They found 
that when compared to low pain sensitive individuals, high pain sensitive individuals 
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displayed significantly increased activation in the anterior cingulate cortex, prefrontal 
cortex, and areas of the somatosensory cortex, which corresponded to areas where the 
pain stimulus was emitted (Coghill, McHaffie & Yen, 2003). Interestingly, the thalamus, 
a primary relay for nociceptive information, was similarly activated in both groups, 
suggesting that psychological factors may have contributed to the differences in pain 
perception (Coghill, McHaffie & Yen, 2003). For example, the thoughts and how much 
attention individuals devote to pain stimuli explain a portion of individual differences in 
pain perception (Coghill, 2010). The authors found that how focused an individual is on 
their thoughts and what thoughts they are currently experiencing both contribute to the 
subject’s inter-individual differences in pain response (Coghill, 2010). For example, 
when participants divided attention between two noxious stimuli simultaneously 
delivered, they experienced reduced pain or even analgesia (Quevedo & Coghill, 2007).  
 
Sex and Gender Differences in Pain Perception 
 In a consensus report among pain researchers, Greenspan and colleagues (2007) 
recommend that both sex and gender be used as constructs when examining group 
differences in pain report between men and women. As there are psychological 
differences between men and women, particularly in their response to stress, and since 
pain is a stressful experience in itself, Greenspan and colleagues (2007) assert that sex 
differences arising from stress influence observed gender differences found in pain 
studies.  
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According to Fillingim (2000), because women are overrepresented in a number 
of chronic pain conditions, and they report increased frequency of pain symptoms, they 
are at increased risk for developing pain conditions. Although women’s higher pain 
sensitivity has been customarily attributed to sociocultural factors, such that feminine 
gender roles allow for the expression on pain, whereas male gender roles discourage such 
expression (Fillingim, 2000), sex differences in pain perception have been found in both 
human and non-human animals. Moreover, Fillingim (2000) forewarns researchers that 
different levels of analysis used for sex and gender may actually describe the same 
underlying processes.  
Wiesenfeld-Hallin (2005) conducted a literature review of pain studies examining 
sex differences in humans and laboratory animals. Dispersed widely in the central 
nervous system, sex hormones influence sensitivity to pain. Thus, pain sensitivity in 
women varies with the menstrual cycle, with increased tolerance during the follicular 
phase rather than the luteal phase, as well as during late pregnancy (Wiesenfeld-Hallin, 
2005). Women are also more regularly afflicted with chronic pain starting in puberty until 
65 years of age (Berkley, 1997; Le Resche, Manci, Drangsholt, Saunders  Korff, 2005; 
Von Korff, Dworkin, Le Resche, & Kruger, 1988). This finding may be confounded by 
the increased rate of depression and anxiety in women, which are associated with 
increases in pain symptoms. For instance, women with chronic pain exhibit greater rates 
of catastrophizing, which is linked to higher pain levels (Keogh & Eccleston, 2006). 
Furthermore, onset of new pain in women can be predicted using the number of existing 
pain conditions (Von Korff, Dworkin, Le Resche & Kruger, 1988).  
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Wise et al. (2002) found that in response to noxious thermal stimuli, women 
reported greater subjective unpleasantness to pain, reduced pain tolerance, and a lower 
mean pain threshold than men. Furthermore, pupillary dilation following painful 
stimulation, an indicator of acute pain, was found to be greater in women than in men 
(Ellermeier & Westphal, 1995). Moreover, women removed their hand from a noxious 
cold stimulus approximately 40% sooner than men did (Kim, et al., 2004).  
Interestingly, and discrepant from animal models, women may receive greater 
benefit from opiate drugs because they self-administered only half as much opiate 
medication as men did post-surgery (Miaskowski, Gear, & Levine, 2000). Concurrently, 
Zubieta et al. (2002) found that after experimentally controlling pain intensity levels 
between men and women, the two genders still differed in the direction and magnitude of 
response to pain in the μ-opioid system in different brain nuclei. Furthermore, research 
examining pharmacokinetic drug properties suggested that the effectiveness of 
medication as well as tolerance to side effects may vary by sex (Gandhi, Aweeka, 
Greenblatt, & Blaschke, 2004). Moreover, while the perceived ability to modulate pain 
response was found in women but not men, the analgesic qualities of cognitive coping 
strategies are reversed by naloxone, an opioid antagonist (Fillingim, 2000; 49-51). Thus, 
men and women may not only differ in pain sensitivity, but also respond differently to 
both endogenous and exogenous analgesics, as well as to substances that disrupt 
analgesic response.  
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Genetic Factors 
 Individual variability in pain perception and response has been linked to genetic 
factors. For instance, individuals with a family history of pain are more likely to 
experience greater sensitivity to painful stimuli (Lester, Lefebvre, & Keefe, 1994; 
Koutantji, Pearce, Oakley, & Feinmann, 1998). Kim and colleagues (2004) were 
interested in examining the role of genetic factors and individual differences in human 
pain sensitivity to cold and thermal stimuli (Kim et al., 2004). Pain sensitivity to the cold 
stimulus was measured as the time it took for participants to withdraw their hand from an 
insulated bucket filled with cold ice water, and intensity ratings were given using a visual 
analogue scale (VAS). Thermal pain intensity ratings were assessed using the VAS to 
which participants rated their pain following the application of quasi-randomized varying 
levels of thermal stimuli to their forearm. Temperament was measured using the 
temperament and character inventory (TCI) in order to assess whether their sample of 
500 subjects scored onto dimensions of persistence, reward dependence, harm avoidance, 
or novelty seeking (Kim, et al., 2004). Genotyping was conducted by Kim and colleagues 
(2004) by collecting 50 ml of venous blood from each participant, and analyzing loci in 
the vanilloid receptor subtype 1 gene (TRPV1), d opioid receptor subtype 1 gene 
(OPRD1), and catechol O-methyltransferase gene (COMT). Results showed significant 
interactions between the TRPVI and ORPDI single nucleotide polymorphisms and 
individual differences such as temperament, ethnicity, and gender to cold and thermal 
pain sensitivity (Kim, et al., 2004).  
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 Specifically, there were significant gender differences for harm avoidance and 
reward dependence, cold withdrawal time, cold pain intensity, and heat pain intensity. 
Females displayed higher heat pain intensity than males at 49º C, and those who scored 
onto the novelty seeking dimension of the TCI showed greater pain resistance than 
females who placed onto the low novelty seeking group. Males who scored high on 
persistence in the two homozygous groups of the ORPD1 Phe27Cys genotypes 
demonstrated reduced thermal pain response at 49º C when contrasted with low 
persistence males (Kim et al., 2004). Thus, while these data confirmed gender as a 
significant factor in response to both cold and hot pain stimuli, temperament in the form 
of harm avoidance, novelty seeking, and persistence further characterized pain response 
(Kim et al., 2004). 
 Regarding ethnicity, European American subjects displayed longer cold 
withdrawal time than the other ethnic groups represented in the study; African 
Americans, Hispanic Americans, and Asian Americans. Furthermore, European 
American males demonstrated longer cold withdrawal time than European American 
females, and European males who scored low on harm avoidance showed longer cold 
withdrawal time than males who scored high on harm avoidance (Kim et al., 2004). 
Overall, the findings point to complicated interactions between genetic variation, gender, 
ethnicity, and temperament.   
 Pain sensitivity within and between individuals can vary not only by pain 
intensity but also by the pain stimulus itself, such that individuals that are sensitive to 
thermal pain may not necessarily be as sensitive to cold presser pain (Kim et al., 2004; 
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Coghill, 2010). Coghill (2010) suggested that while sensory differences between 
individuals are supported by genetic factors, they are also heavily influenced by cognitive 
and psychological factors.  
 
General Psychological Factors  
Psychological factors are known to affect pain perception (Dworkin & Breitbart, 
2004). Grunau, Whitfield, and Petrie (1994) examined pain sensitivity and temperament 
in extremely low-birth-weight premature toddlers and preterm and full term toddlers. 
They found that parents rated the extremely low birth weight premature children, who 
most likely experienced the greatest amount of medical procedures as an infant, and 
therefore psychological trauma, significantly less sensitive to pain, with boys being the 
least sensitive (Grunau, Whitfield & Petrie, 1994). Pain sensitivity ratings were 
significantly correlated with temperament for all groups, except the extremely lowest 
birth weight group (Grunau, Whitfield & Petrie, 1994). Among the toddlers born at full 
birth weight, those highest in emotional reactivity were labeled as more sensitive to 
everyday pain by parents (Grunau, Whitfield & Petrie, 1994). However, early life pain 
sensitivity is only one of many pertinent aspects in the experience of pain. Development 
of pain behaviors is manifested through cultural and psychological factors.  
According to McGrath (1994), pain is a complicated multifaceted perception that 
fluctuates in its intensity, location, length, and noxiousness, and that psychological 
factors such as emotion and context can alter its experience. Due to its capacity to 
differentially respond to equal amounts of tissue damage between and among individuals, 
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the nociceptive system is viewed as plastic (McGrath, 1994). Prior pain experience, 
cognitive level, and psychological factors mold together to change how a person may 
react to a noxious stimulus. Individuals’ understanding of their pain source, their feelings, 
and behaviors in response to pain all affect their perception of pain (McGrath, 1994). 
Individual characteristics presumed to be stable, such as cultural and familial 
experiences, age, and gender, as well as unfixed contextual factors, such as emotions and 
behavior, join together to influence painful experiences (McGrath, 1994). The possible 
roles of the psychological factors of pain perception are displayed in Figure 1 (McGrath, 
1994).  
As gender differences in pain sensitivity are discussed in its own section, the discussion 
of psychological factors on pain will not examine gender differences.    
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While individuals cognitively construe new experiences of pain relative to prior 
painful experiences, differences in pain sensitivity cannot be adequately explained by this 
factor alone (McGrath, 1994). Cultural and familial experiences not only shape our 
expressions of pain, such as crying, but also help us evaluate its severity, and adopt 
coping behaviors, such as whether to seek aid. While typical acute pain does not extend 
distress due to its occurrence from daily activities, repeated medical procedures that 
produce acute pain could be confounded by emotional factors, such as anxiety and 
expectation of pain, that may exacerbate pain perception, as emotional distress has been 
shown to be associated with greater sensitivity to experimental pain (McGrath, 1994). 
Recurrent pain is mitigated by different psychological factors than is acute pain, such as 
negative expectations and perceived lack of control over the painful condition and its 
outcome, causing significant emotional distress for patients and families.  
Continuous or chronic pain may arise from both central and peripheral 
nociceptive mechanisms (McGrath, 1994), and these patients also suffer from emotional 
distress from failed treatments, as well as psychological distress from disabling chronic 
pain. As this literature review focuses primarily on differences in pain sensitivity, chronic 
pain conditions are beyond the scope of this topic. Pain sensitivity is influenced by 
situational factors such as awareness of the source of pain, anticipation of pain relief, 
perceived control, and the subjective significance of pain (McGrath, 1994). In some 
individuals, psychological suffering, such as anxiety, depression, and negative emotions, 
serves to not only increase pain sensitivity, but may also become a consequence of pain 
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experience (McGrath, 1994). For instance, some individuals opt to suppress their 
emotional distress, and instead express it in terms of somatic symptoms.  
 
Psychopathology and Pain Sensitivity 
Patients with depression and anxiety report increased pain levels, which may 
reflect pathology in the levels of serotonin and/or its receptors. Furthermore, depression 
is often comorbid with pain (Greenspan et al., 2007). In a study examining previous pain 
complaints and pain-thresholds in psychiatric in-patients with Major Depressive Disorder 
(MDD) or Panic Disorder (PD), Lautenbacher, Spernal, Schreiber, and Krieg (1999) 
found that both MDD and PD patients reported a significantly greater number of painful 
body sites, as well as significantly greater intensity and unpleasantness of pain history 
compared with healthy controls. The patient groups did not statistically differ from each 
other in pain history (Lautenbacher, Spernal, Schreiber, & Krieg, 1999). Regarding pain 
thresholds to pressure pain and cold-pressor pain, patients with MDD displayed 
significantly higher pain thresholds to pressure pain compared with PD patients and 
healthy controls, and significantly greater pain threshold to cold-pressor pain compared 
with PD patients (Lautenbacher, Spernal, Schreiber, & Krieg, 1999). Patients with PD 
were statistically indistinguishable from healthy controls to all three types of pain stimuli. 
There were no significant differences between the three groups’ heat pain thresholds 
(Lautenbacher, Spernal, Schreiber, & Krieg, 1999).  
Thus, despite reporting greater affliction from clinical pain, psychiatric in-patients 
with MDD displayed increased pain thresholds to noxious stimuli, while patients with PD 
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displayed pain thresholds comparable to those of healthy controls (Lautenbacher, 
Spernal, Schreiber, & Krieg, 1999). Lautenbacher and colleagues’ findings in depressed 
patients reveal the inadequacy of defining pain perception as pain threshold, as this 
definition may not fully explain the expression of pain. Moreover, the researchers 
propose other explanations for the reported elevated clinical pain among these patients, 
such as emotional factors or the endogenous inhibitory pain processing for long-lasting 
pain, both of which were uninvestigated in this study.  
Patients with PD responded normatively to noxious stimuli, and despite 
insufficient power, Lautenbacher and colleagues (1999) suggest a potential relationship 
between perceptual pain and the reported unpleasantness of clinical pain in this group, as 
their trait anxiousness may lead them to detect for unpleasantness in different situations. 
Moreover, when examining pain sensitivity in both comorbid and non-comorbid pain and 
psychiatric patients, Merskey (1965) found that while patients with depression with 
concomitant pain displayed increased pain sensitivity, patients with anxiety and 
concomitant pain displayed reduced sensitivity to pain. Both manuscripts demonstrate 
that pain complaints in psychiatric populations are multifarious, and cannot be elucidated 
through pain sensitivity disparities alone.  
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Chapter Two: 
Alcohol Dependence 
 
Distinguishing Alcohol Abuse from Alcohol Dependence/Addiction 
Alcohol is a legal drug in many countries, and its intermittent use is often socially 
encouraged. Alcohol dependence or addiction to alcohol is distinct from the occasional 
use of alcohol, in that dependence is characterized by compulsive seeking, over limiting 
its intake, and loss of control. According to the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-IV-TR), alcohol dependence occurs when individuals continue 
to use alcohol in spite of significant areas of dysfunction, evidence of physical 
dependence, and/or associated hardship (4th ed., text revision, American Psychiatric 
Association, 2000). Diagnosis for alcohol dependence according to the DSM-IV-TR 
entails at least three of the seven following criteria to manifest within 12 months: 
tolerance; withdrawal symptoms; use in larger amounts than intended; persistent desire to 
cut down; time spent obtaining alcohol or recovering from its effects; reduction in social, 
occupational, or recreational pursuits due to its use; and continued use in spite of 
knowledge of its resulting harm. Alcohol abuse is distinguished from alcohol dependence 
in that individuals who abuse alcohol do not meet criteria for dependence as described 
above, but recurrently use alcohol in maladaptive ways that disrupt their daily 
functioning, and do not show evidence of tolerance or withdrawal symptoms.  
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Cycles of Alcohol Addiction 
 Drug addiction involves characteristics involved in both impulse control disorders 
and compulsive disorders (Koob & Volkow, 2009). Impulse control disorders exhibit an 
escalating sense of arousal prior to commencing an impulsive act, followed by pleasure 
once the impulse is acted upon. This describes the drug-seeking criterion for alcohol 
dependence, where alcoholics seek out the effects of alcohol for its hedonic euphoric 
elements, which is associated with positive reinforcement mechanisms. Positive 
reinforcement occurs when the presentation of a pleasant stimulus (i.e. alcohol) increases 
the probability of a response, as illustrated by an alcoholic continuing to seek out alcohol 
due to its positive effects on mood. Compulsive disorders, in contrast to impulsive 
disorders, exhibit anxiety or negative affect prior to commencing a repetitive behavior, 
followed by relief from enacting the compulsive behavior. This describes the withdrawal 
and tolerance symptoms of alcohol addiction, whereby an alcoholic compulsively seeks 
out alcohol to relieve themselves of withdrawal symptoms or negative affect, which is 
associated with negative reinforcement. In contrast to positive reinforcement, negative 
reinforcement occurs when the removal of an aversive stimulus (i.e. withdrawal 
symptoms) increases the likelihood of a response, as illustrated by an alcoholic 
compulsively seeking out alcohol to reduce symptoms of withdrawal. Impulsivity and 
compulsivity form the cycles of alcohol addiction, where impulsivity predominates 
during the earlier stages of addiction and impulsivity combined with compulsivity 
governs the later stages. According to Koob and Volkow (2009), three stages describe the 
addiction cycle: binge/intoxication, withdrawal/negative affect, and preoccupation/ 
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anticipation/craving, and alcohol addiction occurs when these three stages spiral and 
increase in intensity (Koob & Le Moal, 1997).  
 
Rates of Alcohol Dependence 
According to the World Health Organization (WHO), alcohol addiction is a global 
problem, as stated in the report “Management of substance abuse: Alcohol” (2014), 
alcohol kills approximately 2.5 million people per year at present, which classifies 
alcohol as the third leading risk factor worldwide for disability and death. In the Western 
Pacific and Americas geographical regions, it is the number one factor, while it sits at 
number two in Europe. In 2012, it was estimated that of U.S. citizens over the age of 12, 
52% (135.5 million) drank alcohol, with 8.5% (22.2 million) meeting criteria for alcohol 
abuse or dependence (Substance Abuse and Mental Health Services Administration, 
2012). Thus while alcohol is legal, it is one of the nation’s largest drug problems whether 
measured in terms of mortality, morbidity or social cost. The fact that it is commonplace 
to separate alcohol from illegal drugs in our everyday speech obscures the concerns that 
alcohol shares with other drugs of abuse, and reduces society’s awareness of the grave 
problems associated with alcohol dependence, which in turn hinders the prevention and 
treatment of alcohol dependence (Institute in Medicine, 1996).  
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Treatment 
The need for treatment is apparent for individuals diagnosed with alcohol 
dependence. Three types of treatment for alcohol addiction are pharmacological, in-
patient and outpatient care at a rehabilitation facility, and community support groups such 
as Alcoholics Anonymous (AA). Benefits of treatment beside alcohol cessation include 
improved health and increased productivity. Alcohol dependence is typically a 
chronically relapsing disorder owing to the compulsive drug-seeking behavior and loss of 
control over consumption. Although research has demonstrated that treatment for drug 
abuse is cost effective in decreasing consumption and its associated social and health 
consequences (Institute in Medicine, 1996), few individuals enroll in a treatment facility. 
According to the National Institute on Drug Abuse (NIDA), there continues to be a large 
treatment gap in the US, where in 2012, only 2.5 million people (1 percent) of an 
estimated 23.1 million Americans (8.9 percent) who required treatment related to alcohol 
or drugs actually received treatment at a special facility. Furthermore, rehabilitation 
methods have not proven highly successful, as relapse rates are alarmingly high, 
estimated at 60% one year after receiving a minimum 90-day treatment in a study on 
adolescents (Hser, et al., 2001), which is unsurprising as chronic relapse after prolonged 
abstinence is a hallmark of addiction (Koob & Volkow, 2009). In adults who received 
treatment at a rehabilitation facility, estimated long-term relapse rates have varied 
between 20 and 80% (Jin, Rourke, Patterson, Taylor, & Grant, 1998; Finney, Moos, & 
Timko, 1999). The alarming rate of relapse post treatment may be due to its limited 
duration, as most rehabilitation facilities traditionally offer 28 or 30-day treatments, and 
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research has shown that a minimum of three months is necessary to achieve any sort of 
efficacy (Simpson, Joe, Fletcher, Hubbard, & Anglin, 1999). Relapse describes the return 
to drug use despite attempts to remain abstinent. As it is problematic to study relapse in 
animal models, the neurobiological mechanisms underlying relapse are largely unknown, 
making it difficult to prevent and to treat relapse (Institute in Medicine, 1996). 
Research on treatment research has increased the variety of pharmacotherapeutic 
and psychosocial treatment approaches, and the majority of treatment facilities employ 
both treatment methods (Institute in Medicine, 1996). Pharmacotherapy treatment 
methods include several drugs that have been found effective at helping with alcohol 
addiction, the most used being naltrexone, an opiate antagonist. Opiate antagonist 
medications work by binding to the opioid receptor site, thereby blocking receptor 
activation by alcohol, and thus preventing its euphoric and dependence-producing results. 
This blockade denotes competitive antagonism, and as a result, its medical efficacy may 
be altered by the dose of the antagonist, the time since the antagonist was taken, and 
alcohol dosage. Beside preventing the euphoric and thus reinforcing effects of alcohol, 
naltrexone has also been shown to decrease relapse to alcohol, as half of naltrexone 
treated alcohol dependent outpatients relapsed compared to nearly all (95%) of placebo 
exposed patients (Volpicelli, Alterman, Hayashida, & O’Brien, 1992). However, these 
relapse rates are in outpatients who consumed any alcohol while attending outpatient 
treatment. Differences in placebo and naltrexone treated outpatients who were abstinent 
during outpatient treatment are less sizeable; 23% of naltrexone treated patients relapsed 
compared to 54.3% of placebo treated patients. Thus, while treatment with naltrexone has 
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been demonstrated to be superior to placebo (Streeton & Whelan, 2001), many alcoholics 
continue to relapse.  
As part of a multiple treatment approach, therapists routinely refer alcohol 
dependent individuals to Alcoholics Anonymous (AA), which uses abstinence and 
seeking out a ‘higher power’ to help prevent relapse. There is strong support for this type 
of 12-step approach to trying to help addiction, as well as a spiritual approach in general, 
among staff members at alcohol rehabilitation centers. While AA does not appeal to all 
alcoholics, its approach has been touted as successful with many. Interestingly, scientists 
tend to endorse this type of approach less, including rehab facilities in general, preferring 
a pharmacotherapy approach instead (Forman, Bovasso, & Woody, 2001).  
Thus, while there are available treatments for alcohol dependence that hold 
promise for some individuals, many individuals continue to suffer from the paralyzing 
spiral of alcohol addiction. One theory of why current treatments are not more effective is 
that alcohol dependence is commonly treated as an acute illness, while instead it should 
be treated as a chronic medical illness, as alcohol dependence shares a common etiology 
with many chronic illnesses (McLellan, Lewis, O’Brien, & Kleber, 2000). The persisting 
challenge to alcohol treatment research is to generate additional effective 
pharmacotherapeutic and psychosocial treatments that are not only cost-effective, but 
which are tailored to the unique needs of individual patients (Institute in Medicine, 1996). 
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Addiction Vulnerability 
 Investigating the risk or vulnerability for addiction may provide several insights 
that have clinical implications. Firstly, such findings can help us to identify those at risk 
for developing alcoholism and institute preventative treatments. Secondly, as alcohol is a 
chronic relapsing disorder, individuals who attain abstinence may continue to have 
underlying vulnerabilities to relapse and by addressing them, we may increase the 
effectiveness of treatment. Risk focused approaches are suggested to be the most 
promising strategies for the effective prevention of substance abuse (Dawkins, Catalano 
& Miller, 1992). Overwhelmingly, the majority of research on risk factors or 
vulnerability for alcohol dependence has pointed to having a positive history of familial 
alcoholism, earlier drinking onset and specific personality traits. Additional risk factors 
include physiological vulnerabilities such as biochemical markers and metabolic 
variations.  
 
1. Familial Heritability 
 While prior research has indicated that the onset of drinking at an earlier age was 
a significant risk factor for alcohol dependence in adulthood, Prescott and Kendler (1999) 
found that the relationship between early drinking and later alcohol dependence is due to 
familial causes, which represent both shared genetic and environmental factors. In a 
review on the familial incidence of alcoholism, Cotton (1979) concluded that alcoholics 
were more than six times as likely to be positive for a parental history of alcoholism 
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when compared to non-psychiatric patients, and more than twice as likely to report 
having an alcoholic parent when compared with non-psychiatric patients. The elevated 
rate of alcohol addiction among children of alcoholics indicates family history to be one 
of the most powerful predictors of risk for alcohol dependence, which is partially due to 
genetic influences (Merikangas, 1990). However, in a study examining concordance rates 
for alcoholism among monozygotic and dizygotic twins, Pickens and colleagues (1991) 
found genetic factors to have only a modest influence on overall risk for alcohol 
dependence, suggesting that non-biologically transmitted family characteristics may play 
a substantial role in imparting alcohol addiction. For instance, the mores and behaviors of 
family members and influential community members reinforce the already reinforcing 
properties of alcohol, which poses an underlying risk for the maintenance of abstinence in 
those attempting to recover.  
 Thus, the mechanisms by which familial factors dispatch increased risk for 
alcoholism are yet to be determined. As family studies cannot distinguish genetic from 
environmental influences on the development of alcohol dependence, cross-adoption 
studies provide the clearest model by which to disentangle gene from environmental 
effects. Cross-adoption studies allow us to compare rates of alcoholism in children of 
alcoholics (i.e. those at increased risk for alcoholism) raised by non-alcoholic foster 
parents with those of children of non-alcoholic parents  (i.e. those not at increased risk for 
alcoholism) raised by alcoholic foster parents. Cross-adoption studies have shown that 
children of alcoholics, although raised by nonalcoholic parents, retained a significantly 
increased risk for alcoholism, supporting genetic over environmental effects for the 
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development of alcohol dependence (Goodwin, Schulsinger, Hermansen, Guze, & 
Winokur, 1973; Goodwin et al., 1974; Cadoret, Cain, & Grove, 1980).  
2. Personality Traits and Distinct Subgroups 
 Personality factors may affect the induction of first alcohol use as well as regulate 
the progression of alcoholism. Original groundbreaking research on alcohol dependence 
unveiled that antisocial and aggressive behavior in childhood among boys was 
significantly associated with alcoholism in adulthood (McCord & McCord, 1960; 
McCord, 1981). More recent work by Kellam, Brown, and Ensminger (1983) found that 
heavy alcohol use in adolescence was predicted by aggressive behavior displayed in the 
first grade. Additional personality traits such as aggressiveness and neuroticism were 
found to be directly associated with later substance abuse (Tarter, 1988). The relationship 
between family history of alcoholism, alcohol use, and antisocial personality disorder in a 
sample of young non-alcoholic males was explored by Hesselbrock and Hesselbrock 
(1991). Findings indicated that while interestingly, family history of alcoholism failed to 
differentiate participants on these factors, participants diagnosed with antisocial 
personality disorder reported greater frequency of behavior problems as children related 
to impulsivity and conduct problems, reported drinking at a younger age, and exhibited 
higher scores on an alcohol screening test when compared with non-diagnosed 
participants. These findings suggest that antisocial personality disorder may be its own 
unique risk factor for developing alcohol addiction.  
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 Different studies have shown that while impulsive and antisocial traits preceding 
alcoholism are found in the majority of early onset drinkers, rates are significantly lower 
in later onset alcoholics (Jones, 1968; Hagnell, Lanke, Rorsman, & Ohman, 1986). As 
there is great deal of heterogeneity among individuals afflicted with alcohol addiction, 
examining subgroups may shed light on different vulnerability factors as well as in 
assisting in the formation of targeted treatments and interventions.  
 Research on alcoholism has consistently recognized the existence of two types of 
alcoholism: Type 1 or Type A and Type 2 or Type B, as noted in the literature, whereby 
Type 1 alcoholics are characterized by later age of drinking onset, fewer risk factors from 
childhood, and fewer problems related to alcohol but greater incidence of 
psychopathology relating to anxiety and neuroticism, and Type 2 alcoholics are 
characterized by earlier onset of drinking, greater incidence of childhood risk factors, 
increased severity of alcohol related problems, and an greater history of receiving 
treatment in spite of starting to drink while younger (Jellinek, 1960; Cloninger, 1987; 
Cloninger, Sigvardssin, & Bohman, 1988; Babor et al., 1992; Hawkins, Catalano & 
Miller, 1992).  
 Cloninger (1987) originally differentiated the two groups according to alcohol 
symptom clusters and alcohol transmission patterns derived from adoption studies, and 
further refined the two groups according to the personality traits of novelty seeking, harm 
avoidance, and reward dependence. Type 1 alcoholics are depicted as dependent on social 
approval, therefore displaying high reward dependence; cautious, therefore displaying 
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high harm avoidance; and dislike taking risks, therefore displaying low novelty seeking. 
Unlike Type 1 alcoholics, Type 2 alcoholics are characterized by social detachment or 
antisocial personality; therefore displaying reduced reward dependence; confidence and 
lower inhibition, therefore displaying low harm avoidance; and impulsivity or 
excitability, therefore displaying high novelty seeking. The differentiating attributes of 
the two types of alcoholism proposed by Cloninger (1987) are presented in Table 1. 
 
 
 It is important to take note of Cloninger’s (1987) assertion that these alcoholic 
subgroups should not be regarded as distinct entities of disease as many alcoholics 
demonstrate features of each type, but to recognize that these subgroups may represent 
opposing spectrums of personality traits that may develop as a result of divergent 
alcoholism trajectories. To illustrate, Type 1 alcoholism corresponds to drinking onset in 
late adulthood which is comprised of heavy drinking that is socially reinforced, and is 
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thus associated with a loss of control over drinking, and guilt and fear about developing 
dependence. Type 2 alcoholism, in contrast, corresponds to an early onset of alcohol 
seeking behavior without consideration of actual or potential consequences, such as 
driving under the influence, fighting, and recurring impulsive-aggressive conduct, and is 
thus associated with an incapacity to abstain (Cloninger, Sigvardssin, & Bohman, 1988).  
 Cloninger, Sigvardssin, & Bohman (1988) investigated personality traits in 
children who were later reassessed for alcoholism as adults. They found that high 
novelty-seeking and low harm avoidance predicted alcohol abuse at an early age, and that 
the risk of alcohol abuse ranged from 4% to 75% depending on childhood personality, 
with high-novelty seeking and low harm avoidance predicting a 19-fold increase in risk 
for alcohol abuse. Furthermore, their results were consonant with the typology model of 
alcoholism as the relationship between personality traits and risk for alcoholism was 
strongest for Type 2 alcoholics. 
 Babor and colleagues (1992) found that these two different types of alcoholics 
showed differences in treatment outcome, suggesting that researchers and clinicians may 
benefit from utilizing this dichotomized approach for designing individualized 
treatments. Fittingly, in an effort to evaluate the utility of this typology approach for 
matching patients to more effective treatments, male alcoholics were randomly assigned 
to receive either coping skills training or interactional group psychotherapy. It was found 
that Type A alcoholics benefited more from interactional group therapy, than coping 
skills training, and conversely, Type B alcoholics demonstrated greater improvement 
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from training in coping skills than from attending group therapy (Litt, Babor, DelBoca, 
Kadden & Cooney, 1992). Notably, these differences in treatment response were 
sustained for two years.   
3. Addiction Vulnerability in an Already Vulnerable Population: Adolescents 
 Predominantly, research on drug prevention focuses on adolescents as they 
comprise a population most at risk for developing drug abuse and dependence since 
adolescence is usually the period when most begin to experiment and sample substances 
and when they are most susceptible to the influence of peers. Hawkins, Catalano and 
Miller (1992) reviewed the risk factors as well as protective factors for alcohol abuse in 
adolescence. Some of the identified precursors of adolescent drug abuse include drug 
availability, early drug use initiation, economic hardship, disordered neighborhood, and 
psychological characteristics; such as hyperactivity, aggressive behavior in boys, conduct 
problems, and family risk factors such as low-bonding, high incidence of conflict, and a 
family history of alcoholism and parental use of illegal drugs. The protective factors 
identified were not nearly as comprehensive; there was some evidence that individual 
attributes such as self-efficacy and positive temperament, and ties to mainstream society, 
may protect against drug abuse. Thus, additional research is necessary to discern 
auxiliary protective factors, as well as to discover the relationships between risk and 
protective factors, as protective factors may serve as mediators or moderators of risk, 
especially for risks that are immutable. 
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 As research on different risk factors for alcoholism may vary continuously within 
approximately normal populations, clinicians and researchers are advised to 
conceptualize risk for alcoholism in degrees of probability for alcohol dependence 
instead of differentiating individuals simply as ‘at risk’ or ‘not at risk’ (Cloninger, 
Sigvardssin, & Bohman, 1988).  
 
4. Physiological Vulnerabilities 
4.1 Monoamine Oxidase is a Biomarker for Alcoholism 
 Physiological influences that may increase an individual’s susceptibility to 
alcohol addiction may include neurochemical system impairment and elevated drug 
susceptibility due to one’s own unique biochemistry. Monoamine oxidase (MAO) is an 
enzyme vital for the metabolism of a wide range of neurotransmitters in the brain such as 
serotonin, norepinephrine, and dopamine, and is an extensively studied biological marker 
for alcoholism. An assortment of research studies have found reduced platelet MAO 
activity among abusers of alcohol (Tabakoff et al., 1988; von Knorring, Bohman, von 
Knorring & Oreland, 1985; Pandey, Fawcett, Gibbons, Clark & Davis, 1988).  
 Tabakoff and colleagues (1988) failed to locate significant differences in MAO 
activity between alcoholics and controls, but alcoholics demonstrated increased rates of 
MAO platelet inhibition after being administered alcohol. An innovative study 
investigated whether MAO platelet levels differed between Type I or Type II alcoholics 
(von Knorring, et al., 1985), the same subgroups as described above. Findings indicated 
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platelet MAO activity levels effectively distinguished between the two the two types of 
alcoholism, supporting its role as a biomarker for alcohol addiction. When compared with 
healthy nonalcoholic individuals, platelet MAO activity was low in Type II alcoholics, 
but normal in Type I alcoholics. Moreover, first-degree relatives of participants with 
Type II alcoholism exhibited greater rates of alcoholism and depression than relatives of 
Type I alcoholics. Similarly, Pandey and colleagues (1988) found that alcoholics who 
exhibited low MAO platelet levels were younger in age, had an earlier age of onset of 
alcoholism, and had increased incidence of alcoholism in the family, echoing the 
characteristics of Type II alcoholics. This suggests that Cloninger’s (1987) subdivision of 
alcoholism into two types appears to bestow merit for future studies interested in 
examining the underlying causes of alcoholism and its treatment. 
 
4.2 Metabolic Variations 
 Efficient metabolism of alcohol may increase the risk for alcohol dependence by 
permitting increased amounts for digestion, and thus may mediate the transition from 
alcohol abuse to alcohol dependence. Schuckit (1984, 1985) studied the effects of alcohol 
on young men who consumed alcohol but who did not meet criteria for alcohol disorders, 
and who were categorized as at risk for developing alcohol dependence due to having a 
family history of alcoholism. The earlier study found that men at risk for alcoholism 
described fewer acute feelings of subjective intoxication after drinking, when compared 
with similarly matched men who did not have an alcoholic first degree relative (Schuckit, 
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1984). In the latter study, Schuckit (1985) investigated physical indicators of alcohol 
intoxication by indexing level of body sway and found that men with a family history of 
alcoholism displayed significantly less body sway after consuming alcohol than men 
without a history of alcoholism in their family. The dual findings of decreased intensity 
of both subjective and physical reactions to alcohol in those at risk for alcoholism provide 
support for efficient metabolism to be a marker for susceptibility toward developing 
alcohol dependence.  
 On the other hand, less efficient metabolism of alcohol may serve as a protective 
factor against developing alcohol dependence. For example, many Asians are biologically 
buffered from becoming alcohol dependent due to a polymorphism of liver enzymes that 
Caucasians don't manifest (Yoshida, 1983; Higuchi et al., 1995; Yoshida, 1994). One of 
these liver enzymes, the inactive form of alcohol dehydrogenase-2 (ADH2) permits high 
levels of acetaldehyde to accrue in the blood subsequent to alcohol ingestion, which 
causes an adverse reaction in the form of a flushing response, which generates a 
protective influence by preventing further alcohol ingestion, and may reduce risk for 
developing alcoholism  (Thomasson et al., 1991; Bosron & Li, 1986).  
 Thus, the inability to metabolize alcohol may serve as a protective factor, 
especially when exposure to alcohol is recurring, while the efficient metabolism of 
alcohol allows for increased alcohol consumption that may increase susceptibility for 
alcohol addiction or facilitate the transition from alcohol abuse to dependence.  
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Chapter Three: 
Link between Pain Sensitivity and Alcohol Addiction 
 
Alcohol Dependence and Pain  
According to Ilgen and colleagues (2010), there are several hypotheses explaining 
the concurrence of alcohol dependence and pain including self-medication, stress-
diathesis, and common underlying risk factors. A unique comorbidity hypothesis is 
unlikely appropriate, as while some research has shown chronic pain to be a risk factor 
for substance use disorders (Brown et al., 1996; Larson et al., 2007), others have 
demonstrated that substance use disorders predate pain conditions (Dersh et al., 2007). 
These compound findings elicit inquiry as to whether pain sensitivity triggers alcoholism 
or vice-versa. 
 
1. Analgesic Effects of Alcohol 
Reports show that as many as a quarter of individuals experiencing pain self-
medicate with alcohol (Riley & King, 2009). Wolff, Hardy, and Goodell (1942) found 
that alcohol increases pain thresholds up to 45% above baseline pain levels. A review by 
Pihl and Peterson (1992) showed evidence that alcohol administered at pharmacological 
dosages has analgesic effects, and that these effects negatively reinforce drinking because 
alcohol reduces pain and discomfort. Thus, individuals who drink alcohol experience 
pain reduction, making them more likely to drink when in pain, demonstrating alcohol’s 
negative reinforcement properties. Pihl and Peterson (1992) suggest that alcohol is most 
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reinforcing to individuals with greater sensitivity to pain. The pleasant hedonic state 
conferred by addictive substances is related to the neutralization of pain, as related 
neuroreceptor systems are implicated in both alcohol’s reinforcing effects and its 
analgesic consequences (Le Magnen et al., 1980), discussed in its own section below.  
In an effort to alleviate undertreated pain, individuals seeking out the analgesic 
quality of drugs are described as pseudoaddicts (Weissman & Haddox, 1989). Although 
pseudoaddicts display medication-seeking behavior that mirrors true addiction behavior, 
they are driven to obtain substances to relieve pain, as opposed to obtain substances to 
abuse. Nevertheless, it is likely for individuals to transition from pseudoaddiction to true 
alcohol dependence as extensive experience with alcohol has led users to expect pain 
relief (Cutter et al, 1976), and evidence suggests that individuals favored alcohol dosage 
may provide the greatest amount of pain relief (Brown & Cutter, 1977). Thus, the 
analgesic effects of alcohol may cause individuals to become susceptible to dependence.  
 
2. Hyperalgesic Effects of Alcohol 
Increased pain in alcoholics may be explained by withdrawal mechanisms, 
peripheral neuropathy, or the existence of chronic pain. The link between pain sensitivity 
and addiction to alcohol is complex in that alcohol use in humans not only reduces their 
sensitivity to pain due to its analgesic qualities as described above, but withdrawal from 
chronic alcohol consumption frequently increases pain levels, as part of withdrawal 
mechanisms. Furthermore, patients characterized with greater severity of withdrawal 
displayed reduced pain threshold and tolerance (Jochum, Boettger, Burkhardt, Juckel, & 
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Bar, 2010). Similarly, when deprived of alcohol, ethanol dependent rats display 
attenuated nociceptive thresholds when compared to non-dependent controls (Dina, 
Messing, & Levine, 2006).  
Chronic alcohol consumption has been shown to influence the development of 
neuropathic pain in the duration of its use (Koike et al., 2003; Zambelis, Karandreas, 
Tzavellas, Kokotis & Liappas, 2005). Moreover, the development of neuropathic pain 
during alcohol withdrawal may signify a crucial symptom that distinguishes alcohol 
dependent individuals from alcohol abusers (Diamond & Messing, 1994). Alcohol 
withdrawal can further exacerbate neuropathy (Dina et al., 2006). The research described 
above may indicate that desire to lessen the effects of hyperalgesia induced by 
withdrawal is a motivational factor for continued drinking. The current literature has not 
addressed if alcohol induced neuropathic pain is also attenuated by alcohol in chronic 
alcoholics.  
 While not addressed in detail in the pain sensitivity section above, it is important 
to examine the relationship between chronic pain and alcoholism. While it is claimed that 
a significant percentage of chronic pain patients are afflicted with drug addiction, 
Fishbain, Rosomoff and Rosomoff (1992) investigated its veracity by reviewing relevant 
articles. They found that among chronic pain patients, the prevalence percentages for 
diagnosed drug addiction ranged from 3.2% to 18.9%, but that there is at best only 
modest support that chronic pain patients exhibit addictive behaviors. Thus, it remains 
unclear whether alcohol use influences the development of chronic pain.  
 
33 
3. Mixed Effects of Alcohol 
Alcohol use normalizes pain and perceptions of discomfort in excessive alcohol 
users, as they are more sensitive to painful stimulation, and experience greater pain 
reduction after imbibing (Stewart et al., 1995). However, continuing alcohol use can 
induce symptoms of pain, and may worsen chronic pain stemming from other sources 
(Egli, Koob & Edwards, 2012). Thus, while individuals in pain may seek out the 
analgesic effects of alcohol, the continued use of alcohol may exacerbate pain, further 
complicating the question as to whether pain leads to addiction or vice-versa. 
In a longitudinal study following older community residents, Brennan, Schutte, 
and Moos (2005) showed that problem drinkers reported increased severity of pain 
symptoms and a higher frequency of self-medication with alcohol, when compared to 
non-problem drinkers,. Interestingly, both baseline levels of increased body pain and 
increased drinking problems independently predicted increased self-medication with 
alcohol, suggesting that pain and alcohol abuse both lead to increased frequency with 
which alcohol is used to manage pain. Additionally, a significant statistical interaction 
between the number of drinking problems and pain severity independently predicted 
alcohol self-medication among problem and non-problem drinkers (Brennan et al., 2005; 
See Figure 2).  
At higher levels of pain, self-medication was more likely to occur among both 
problem and non-problem drinkers. Nevertheless, this effect was most pronounced 
among problem-drinkers. Furthermore, findings displayed a significant interaction 
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between the use of alcohol to manage pain on chronic health problems and baseline 
drinking problems among men (Brennan et al., 2005; See Figure 3).  
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Moreover, three years later, persistent self-medication with alcohol in problem 
drinkers caused an exacerbation of drinking and health problems. Conversely, individuals 
who discontinued the use of alcohol to manage pain drank less at follow-up. These 
individuals may have diminished their risk for additional future health problems. These 
findings may point to a complicated relationship between pain and alcoholism whereby 
increased pain leads individuals to drink, and those who continue to drink to manage pain 
experience greater health problems, resulting in more pain. Brennan and colleagues 
(2005) recommend screening for alcohol dependence in older adults as their findings 
suggest that older individuals with drinking problems are at greater risk for self-
medicating with alcohol to manage pain, which can cause greater health problems.  
Jochum and colleagues (2010) investigated pain perception, pain threshold, and 
pain tolerance among alcoholics undergoing withdrawal at admission for treatment, at 
discharge, abstinent alcoholics, and normal controls. While not discussed in detail, they 
found that abstinent alcoholics most resembled healthy controls in that they exhibited 
greater thermal pain threshold and pain tolerance than alcoholic patients. This suggests 
that the hyperalgesic effects of alcohol can disappear after a period of abstinence.  
 
Neural Mechanisms Involved in Pain and Alcohol Addiction 
1. Neuroreceptors and Neurotransmitters 
In a review on the reciprocal relationship between alcohol dependence and pain, 
Egli, Koob, and Edwards (2012) discuss how similar neuroreceptor systems implicated in 
pain transmission are also implicated in alcohol addiction. Neurons responsive to pain are 
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plentiful in the lateral part of the central amygdala (Bernard & Besson, 1990). Alcohol 
causes the release of several neurotransmitters in the central nucleus of the amygdala 
such as GABA, dopamine, and serotonin (Yoshimoto et al., 2000). Drugs of abuse such 
as alcohol promote the release of dopamine into the nucleus accumbens (NAc), and while 
the exact mechanisms are unclear, the release of dopamine along the mesolimbic pathway 
is presumed to account for encouraging the reinforcing effects of such substances 
(Boileau et al., 2003; Pierce & Kumaresan, 2006). Similarly, following the offset of pain 
stimulation, fMRI studies have shown increased activation relative to baseline in the NAc 
(Becerra & Borsook, 2008).  
Neugebauer and colleagues (2003) found that upregulation of presynaptic 
metabotropic glutamate receptors is necessary for the increased excitatory 
neurotransmission in the central nucleus of the amygdala, often called the nociceptive 
amygdala, which is associated with pain related neuroplasticity in arthritis patients. 
Alcohol has been shown to amplify glutamate levels in the central nucleus of the 
amygdala in animals that are alcohol dependent (Roberto et al., 2004). Similarly, arthritic 
animals show increased excitation in this region, which is reduced after receiving 
corticotrophin releasing factor (CRF1) receptor antagonists (Ji & Neugebauer, 2007). 
This suggests that the amygdala and the release of several neurotransmitters in that region 
are related to the modulation of pain levels as well as being affected by drug dependence.  
Increased glutamatergic transmission in the NAc is also implicated in the 
development of addiction (Apkarian et al., 2013). Blockade of the CRF1 receptor, 
commonly associated with stress behaviors also alleviates hypersensitivity of pain in 
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animal models (Hummel et al., 2010) including hyperalgesia during alcohol withdrawal 
(Edwards et al., 2012). In humans, CRF function is activated during acute withdrawal 
from alcohol, and therefore may mediate facets of stress related to abstinence (Koob, 
Heinrichs, Menzaghi, Pich, & Britton, 1994). Moreover, human patients expecting pain 
diagnosed with irritable bowel syndrome displayed reduced limbic over-reactivity in the 
insula, anterior cingulate cortex, and amygdala when administered CRF1 blockade 
(Hubbard et al., 2011). 
 
1.1 Neuroreceptors Implicated in Withdrawal and Hyperalgesia 
 Neuroadaptations within the central nervous system (CNS) must occur to 
maintain functioning in the brain during alcohol dependency, and further adjustments 
between excitatory and inhibitory neural mechanisms take place during alcohol 
withdrawal (Jochum et al, 2010). GABA is the main inhibitory and glutamate is the main 
excitatory neurotransmitter in the mammalian cortex (Petroff, 2002). While the research 
on neural substrates of alcohol withdrawal is limited, neuropharmacological mechanisms 
such as a decrease in GABAergic function and an increase in glutamatergic function has 
been found (Grant, Valverius, Hudspith, & Tabakoff, 1990). Mhatre and colleagues 
(1993) propose that hyperalgesia during alcohol withdrawal may be due to the inhibition 
of GABA-A receptor activity. Correspondingly, increased transmission of glutamate, the 
metabolic precursor of GABA (Petroff, 2002), may be linked to pain sensitization, as 
indicated in opioid induced hyperalgesia (Simonnet & Rivat, 2003). These findings seem 
to suggest that GABA related neuroreceptors and neurosynaptic pathways provide a key 
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link between the pain related effects of alcohol and the mechanisms involved in alcohol 
dependency.  
 
2. Neural Circuitry 
Parallel central reward brain circuitry involving the nucleus accumbens (NAc), 
medial prefrontal cortex (mPFC), and emotion circuitry such as the amygdala and insula, 
implicated in addiction, are also important in the development of pain pathology 
(Apkarian et al., 2013).  
 
2.1 Amygdala and Medial Prefrontal Cortex (mPFC) 
Apkarian and colleagues (2013) propose a model linking the mPFC and the 
amygdala, a region essential for emotional processing, whereby abnormal amygdala 
activation instigates the affective facets of pain, disrupting important mPFC functioning 
necessary for emotional processing and decision-making. Dysfunction of the mPFC is a 
biomarker of behavioral disinhibition, a key characteristic in drug addiction. Several 
studies have established correlations between amygdala activity and pain response 
(Neugebauer, Weidong, Bird & Han., 2004; Neugebauer, Galhardo, Maione & Mackley, 
2009). Moreover, it has been shown that pain can be elicited or increased in animal 
models even in the absence of tissue damage by increasing amygdala activation (Bourbia 
Ansah, & Pertovaara, 2010; Myers & Greenwood-Van, 2010).  
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2.2 Connectivity between Nucleus Accumbens (NAc) and mPFC 
In a groundbreaking study, Baliki and colleagues (2012) found that significant 
differences in brain gray matter density and level of functional connectivity between the 
mPFC and NAc predicted long-term pain trajectory, and differentiated chronic pain 
patients from those who recovered. It was inferred that the degree of exchange between 
the mPFC and NAc pointed to the hyperexcitability of mesolimbic circuitry, leading to 
cortical reorganization, and facilitated unremitting pain in some patients. One study 
implicating the NAc as central to both pain and addiction showed that the NAc was 
activated by cues predicting pain, and that dopaminergic inputs to the NAc signal both 
punishment and reward, which are implicated in addiction processes (Ungless, Magill, & 
Bolam, 2004). Moreover, human and animal models of addiction have established that 
dysregulation of the NAc-mPFC reward circuitry is important in the development of drug 
addiction (Kalivas & Volkow, 2005). For instance, it has been shown that this NAc-
mPFC circuitry is involved in the transition from recreational drug use to drug addiction 
(Kalivas & Volkow, 2005).  
 
2.3 Insular Cortex 
Chronic back pain patients showed decreased gray matter density in the right 
insula and reduced functional connectivity between the insula and the dorsolateral 
prefrontal cortex and precuneus (Baliki et al., 2012). This reduced functional connectivity 
was negatively correlated with pain intensity, but positively associated with gray matter 
density in the insula (Baliki et al., 2012). Baliki and colleagues (2012) interpret these 
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findings in that the persistence of pain may be directly related to functional 
reorganization of the insula. Naqvi and colleagues (2007) implicated the role of insula in 
addiction by showing that smokers with brain damage to the insula found quitting 
smoking to be easier. According to Tracey (2011), functional neuroimaging studies 
pinpoint the insular cortex as the most regularly activated region in pain studies in 
humans. When anticipating rewards or losses, individuals with a positive family history 
for alcohol addiction and a variant of the GABA2 gene display elevated responding in the 
insula (Villafuerte et al., 2012).  
 
Genetic Influences on Pain and Alcohol Addiction 
1. Genetic Heritability  
Stewart, Finn and Pihl (1995) found that men high in risk for alcoholism, as 
determined by genetic load, rated electric shock as more painful than low risk controls. 
However, these effects disappeared when administered pharmacologically significant 
levels of alcohol, demonstrating the “normalizing” effect of alcohol on pain. These 
findings are consistent with the work of Brown and Cutter (1977), who found that alcohol 
increases problem drinkers’ ability to cope with pain. However, unlike Brown and Cutter 
(1977), the findings of Stewart, Finn and Pihl (1995) showed no group differences 
between men at high risk versus those low in risk for alcoholism in weekly alcohol 
consumption, and that pain ratings were uncorrelated with dosage consumed. The 
investigators proposed that men with a multigenerational history of alcoholism were 
likely to be more sensitive to pain prior to alcohol initiation. Thus, men higher at risk for 
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alcoholism may be more sensitive to pain due to genetic factors or to having been 
brought up in a disordered family atmosphere (Stewart, Finn & Pihl, 1994). The negative 
reinforcing effects of alcohol, whereby alcohol intake is more likely to take place in order 
to avoid pain, may be mediated by the opiate system (Altshaler et al., 1980).  
 
2. Genetic Variation 
The pathophysiology of substance dependence including alcohol addiction is 
associated with the endogenous opioid system (Bodnar & Hadjimarkou, 2003). OPRM1, 
a gene that codes for µ-opioid receptors has been identified as a candidate gene for 
developing addiction including alcohol dependence, and ranks highly according to 
criteria prioritizing it as a candidate gene in studies on pain (Ray & Hutchison, 2004; 
Belfer et al., 2004, respectively). While there has been no study to date examining the 
effects of OPRM1 genotype on alcohol addiction and pain sensitivity simultaneously, 
Ray and Hutchison (2004) investigated associations with alcohol sensitivity, and 
Fillingim and colleagues (2005) examined associations with pain sensitivity.  
Ray and Hutchison (2004) investigated whether alcohol sensitivity is associated 
with specific variants of the A118G functional polymorphism of the OPRM1 gene, as 
prior work has shown the G variant to demonstrate a significantly stronger affinity than 
the A variant for binding with β-endorphin, an endogenous opioid which activates the µ-
opioid receptor (Bond et al., 1998). Methodology important to the Ray and Hutchison 
(2004) study included administering alcohol intravenously to participants, and isolating 
genomic DNA from buccal cells via cheek swabbing. As expected, findings indicated 
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greater reported sensation of euphoria, stimulation, and intoxication across increasing 
breath alcohol concentration trials among individuals heterozygous for the G allele (AG) 
of the OPRM1 gene when compared with homozygous A (AA) allele individuals (Ray & 
Hutchison, 2004). Importantly, there were no differences between the groups on 
measures of drinking problems, frequency, or episodes. 
Interestingly, Ray and Hutchison (2004) found that G allele carriers were three 
times more likely than homozygous A allele participants to report a family history 
positive for alcoholism, suggesting that children of alcoholics may be more likely to carry 
the G allele. Nevertheless, controlling for family history did not alter the findings. These 
findings may support previous research demonstrating that naltrexone, an opiate 
antagonist which reduces alcohol related euphoria, to be a more effective treatment for G 
allele carriers than homozygous A allele individuals (Oslin et al., 2003).  
Fillingim and colleagues (2005) investigated genetic contributions associated with 
pain perception in humans. They found that participants with the rarer G allele of the 
A1186 single nucleotide polymorphism of the µ-opioid receptor gene (OPRM1) 
exhibited significantly higher pressure pain thresholds than those homozygous for the A 
allele (Fillingim et al., 2005). They also found a sex by genotype interaction for G allele 
carriers, indicating men were less sensitive than women were to a heat pain stimulus of 
49°C.  
The work of the above investigators demonstrates that the A1186 variant of the 
OPRM1 gene is associated with sensitivity to both alcohol and pain. While Ray and 
Hutchison (2004) showed G allele carriers to be more sensitive to the effects of alcohol, 
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the findings of Fillingim and colleagues (2005) conversely displayed G allele carriers as 
less sensitive to the effects of pain. Although it is difficult to reconcile these 
counterintuitive findings, it is important to note that while Fillingim and colleagues 
(2005) controlled for sex in all genotype analyses, Ray and Hutchison (2004) failed to 
employ sex as a covariate in their analyses, as they accounted for sex by modifying 
alcohol concentration administrations according to the sex and weight of their 
participants.  
Addiction to alcohol is mediated by environmental factors such as early life 
stress, which may influence genetic susceptibility (Clarke et al., 2011). While it is 
recognized that dopaminergic signaling mediates the reinforcing features of alcohol, there 
is limited genetic evidence for the effects of stress on alcohol reinforcement. Clarke and 
colleagues (2011) investigated the genetic links between early life stress and alcoholism 
by examining the KCNJ6, a gene that encodes GIRK2, a protein augmented by the stress 
peptide corticotrophin-releasing hormone (CRF). According to Ikeda and colleagues 
(2002), the GIRK channel is potentially one of the key molecules in furthering the 
understanding of the pain control system. Clark and colleagues (2011) found that the 
rs2836016 polymorphism of the KCNJ6 gene was associated with alcohol dependence in 
adults, and then in a subsequent sample of adolescents at risk for alcoholism, found this 
polymorphism was significantly related to increased hazardous drinking in adolescents 
characterized by early life stress. Clarke and colleagues (2011) interpret their findings by 
stating that the effects of early life stress in adolescents is moderated by KCNJ6 gene via 
dopaminergic signal disruptions, which enhances the rewarding effects of alcohol, thus 
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increasing the potential for alcohol abuse in adulthood. Moreover, stress may further 
enhance predisposition through the effects of cortisol on GIRK2 levels in the brain. Early 
life stress may also increase pain vulnerability. Nishizawa and colleagues (2009) found 
an association between KCNJ6 gene polymorphisms and increased demand for pain relief 
among individuals recovering from major abdominal surgery.  
 
2.1 Genetic Variation Mediates Pharmacological Treatment Effects 
 There have been genotype effects that increased or decreased the effectiveness of 
the treatment drugs Naltrexone, Acamprosate, Tiapride, and Bromocriptine. Naltrexone, 
an opiate antagonist, is one of the most used drugs for treating alcohol addiction. Its 
highest affinity is for the µ-opioid receptor gene OPRM1. Subjects with the G allele 
responded the most positively to this treatment, as did those with the T allele of the 
GABA receptor gene GABRA6. With the GABA receptor, Acamprosate had better 
results with C allele subjects. Nalmefene is another opioid receptor antagonist that is used 
to help treat alcohol addiction, though it is not as effective as naltrexone for individuals 
with the polymorphisms of OPRM1. Nalmefene has not been found to be affected by 
genotype. Tiapride effectiveness is reduced for A/A genotypes of the DRD2 gene, while 
Bromocriptine effectiveness is enhanced in subjects with at least one A1 allele of the 
Taq1A polymorphism, found in the ANKK1 gene (Sturgess, George, Kennedy, Heinz, & 
Muller, 2011).    
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3. Genetic Variation & Neural Mechanisms 
Dopaminergic circuitry, sensitive to stress in both human and non-human animals, 
may operate differently in individuals susceptible to psychiatric illnesses including 
addiction (Mickey et al., 2012). The role of disordered dopaminergic projections from the 
midbrain to the striatum is recognized in addiction (Mickey et al., 2012). Mickey and 
colleagues (2012) investigated striatal dopamine release and genetic variation of the 
serotonin 2C receptor, implicated in neuropsychiatric disorders, in humans subjected to 
moderate deep muscular pain. DNA was extracted and genotyped using blood collected 
from participants, which was used to categorized participants as Ser23 carriers and non-
carriers. They hypothesized that individuals carrying the Ser23 variant of the serotonin 
receptor gene (HTR2C) would display greater sensitivity in dopaminergic circuitry as 
indexed by positron emission tomography (PET) and quantifying D2/D3 radiotracer 
receptor, binding before and after a validated pain challenge.  
Mickey and colleagues (2012) found that Ser23 carriers exhibited greater 
dopamine release in the putamen, caudate nucleus, and nucleus accumbens, 
demonstrating that the Ser23 allele of the human serotonin receptor gene (HTR2C) is 
related to greater striatal dopamine release during the experience of pain in healthy 
individuals. Moreover, HTR2C Ser23 allele genotype accounted for 12% of the variance 
of dopamine release. Interestingly, Mickey and colleagues (2012) further explored 
whether the relationship between the serotonin receptor gene and release of dopamine 
was explained by differences in pain sensitivity, and found that after adding pain 
sensitivity and pain score as covariates, the pain by Ser23 interaction persisted in the 
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nucleus accumbens, but was weakened in the putamen and caudate. Mickey and 
colleagues (2012) interpret their finding of increased stress-provoked dopamine release 
among Ser23 carriers by proposing that greater mesoaccumbal stress reactivity may 
increase the risk of psychiatric disorders among these individuals. The findings of 
Ebstein and colleagues (1997) lend partial support to this proposal as they found Ser23 
carriers displayed reduced traits of reward dependence and persistence, which are 
implicated in addiction.  
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Chapter Four:  
Conclusion 
 Pain sensitivity is affected by the interaction of biological, sociocultural, and 
psychological factors. Pain sensitivity plays an important role in alcohol dependence as 
the analgesic and hyperalgesic effects of alcohol influence the course of addiction and 
may significantly influence relapse. Alcohol dependence is a chronically relapsing 
disorder, with individuals showcasing tremendous difficulty to remain abstinent despite 
availability of pharmacological and community treatments. While alcohol can initially 
provide pain reduction, continuing alcohol use leads to reduction in pain tolerance. 
Moreover, individuals who continue to consume alcohol to manage pain have a worsened 
prognosis. Thus, while pre-existing alcohol addiction is a possible risk factor for 
increased pain, pain sensitivity may play a significant role in the development or 
continuation of alcohol dependence, and longitudinal prospective studies are necessary to 
shed light on the direction of causality between pain and alcoholism (Turk, 1997). The 
link between pain and alcohol addiction is further supported in that the neural circuitry 
that mediates pain response is also implicated in addiction processes. This literature 
review demonstrates strong support for the existence of a link between pain sensitivity 
and alcohol dependence. 
 
Directions for Future Research 
While the studies reviewed have demonstrated that there exists a potential link 
between pain sensitivity and addiction potential, future studies should investigate the 
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causal direction of such a link. For instance, does heightened pain sensitivity lead to 
addiction? Conversely, are individuals who are less sensitive to pain protected from 
developing addiction? Delving into these questions in empirical research can offer 
groundbreaking insights into the interminable hold of alcohol addiction. Beneficial 
studies may include examining adolescents’ pain sensitivity to stimuli presented during 
functional magnetic resonance (fMRI) scanning and seeing if pain sensitivity is indexed 
by genetic factors or a family history of alcoholism. Moreover, it would be fascinating to 
determine if pain sensitivity can be altered by treatment with neurofeedback or 
meditation training, and if such treatment would buffer those at risk for alcoholism from 
developing alcoholism. A recent fMRI study by Zeidan and colleagues (2011) showed 
significant reductions in ratings of pain intensity and unpleasantness in individuals who 
underwent meditation training. The hope would be that this type of preventative 
treatment may protect those at risk from developing alcohol dependence. 
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